The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.

Drugmaker Sarepta Therapeutics said it won’t comply with a request from the FDA to halt all shipments of its gene therapy ...

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Russia is open to peace in Ukraine, but insists achieving its goals remains the priority. On Sunday, Kremlin spokesman Dmitry ...

Officials in a Texas hill country community pummeled by deadly flooding on July 4 say just three people remain missing, down ...

While the North Chicago, Illinois-based healthcare giant estimated its adjusted diluted earnings per share for Q3 could reach $1.28 - $1.32 compared to $1.33 in the consensus, its full-year outlook ...

Emirati conglomerate Al-Futtaim is to buy a 49.95 percent stake in Saudi Arabian franchiser Cenomi Retail in a deal worth ...

A multi-vehicle crash on Saturday afternoon has closed down all lanes on Route 309, according to Lehigh County officials.

When men delay or avoid their healthcare needs it can impact women caregivers' health. Catherine Corriveau, with Movember, joins Jennifer Palma to discuss a study put out by UBC.

Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...